Trials / Unknown
UnknownNCT00822991
Sonazoid Enhanced Liver Cancer Trial for Early Detection
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 760 (estimated)
- Sponsor
- Kindai University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to prove usefulness of contrast-enhanced ultrasound (CE-US) using Sonazoid (TM) in the early detection of HCC as compared with conventional B-mode ultrasound (B-mode US) for hepatitis virus related cirrhosis, who are defined as super high-risk patients for hepatocarcinogenesis,Furthermore, to analyze whether early detection of HCC by CE-US has a survival benefit than that by B-mode US.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CE-US (Sonazoid™) | screening by CE-US using Sonazoid(TM) in the postvascular phase every 3-5 months |
| DEVICE | B-mode US | screening by conventional B-mode US every 3-5 months |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2009-01-15
- Last updated
- 2010-12-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00822991. Inclusion in this directory is not an endorsement.